pdufa
saveSanofi — teplizumab (PDUFA)
community read0 votes
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Data sources
globaldata
Found something off?
same company · ±60 days · 3
- phase 3 completionmeningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi): Sanofi — meningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi) (Phase III Trial Completion)Apr 27, 2026
- earningsSanofi earningsApr 23, 2026
- approvalXYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approvalMar 5, 2026
related news · 8
- statSTAT+: FDA leadership shakeup widens following Makary’s departure
- statSTAT+: Colombia wins a key court ruling over a compulsory license issued for an HIV medicine
- statSTAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and more
- onclivePost–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer
- statTrump reportedly plans to fire FDA Commissioner Makary
- statSTAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug
- statSTAT+: Up and down the ladder: The latest comings and goings
- statSTAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more
comments(0)
5-min edit window · permanent after that